| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7507840 | Drug and Alcohol Dependence | 2012 | 6 Pages |
Abstract
Co-administration of lersivirine (1000Â mg QD) with methadone did not result in clinically relevant changes in R-/S-methadone concentrations or opioid withdrawal symptoms. No methadone dose adjustment is required when lersivirine is administered alongside MMT.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Manoli Vourvahis, Rong Wang, Daniel Mark Gruener, R. Douglas Bruce, Seema Haider, Margaret Tawadrous,